BioStem Technologies (OTC: BSEM)
Patrick Daly is an accomplished executive with extensive experience in the life sciences and medical technology sectors. Currently serving as an Independent Director at BioStem Technologies and Global Vice President at IQVIA, Patrick has a proven track record in strategic leadership, revenue generation, and market measurement. Previous roles include Chairman and Independent Director at AdvaMed, Advisor at Pappas Capital, and President and CEO at Cohera Medical, where notable achievements included significant revenue growth and product innovation. Patrick's career also encompasses a range of positions at Johnson & Johnson, contributing to major advancements in medical technologies and sales performance. A graduate of the United States Military Academy at West Point, Patrick holds a Bachelor of Science degree in Foreign Area Studies.
This person is not in the org chart
This person is not in any teams
BioStem Technologies (OTC: BSEM)
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.